VIM and prostate carcinoma: Like miR-200a and miR-200b, miPEP-200a and b over-expression in prostate cancer cells inhibits migration of these cells by regulating the vimentin-mediated pathway, suggesting that the miPEP-coding function of pri-miRs is present in humans [18].